Jeffrey B. Shealy

Jeffrey B. Shealy (chief executive) discloses dealings in 3 companies, chiefly Akoustis Technologies, Inc., Blue Laser Fusion, Inc. and Palomino Laboratories Inc. We count 61 filings; the first trade dates from 20 December 2017 and the latest from 30 September 2026.

Both buying and selling appear: 1 purchase worth €604k, against 46 sales worth €10.7M. The net balance comes to €10.1M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 9 share grants and 1 option exercise.

On 5 October 2026 came the latest disclosure, a transaction for €88k in Blue Laser Fusion, Inc. The last insider purchase was made public on 31 January 2024, 998 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.